Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
No Image Available

Beractant 100 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 100 mg

Reference Brands: Survanta (US)

Category: Respiratory Disorder

Injection (Beractant) is a prescription medicine used to treat the symptoms of respiratory distress syndrome in premature babies. It is a natural surfactant that is extracted from bovine lungs.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: It is used to treat severe breathing difficulties in babies, due to respiratory distress syndrome. Premature babies, in particular, are at a huge risk of developing respiratory distress syndrome due to inadequate production of a substance called surfactant by the lungs.

Beractant — third party manufacturing & bulk supply

Beractant 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Beractant is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Beractant listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Beractant →
Back to Listing

Frequently Asked Questions

BERACTANT is listed as Injection in 100 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

BERACTANT is referenced against Survanta (US). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Beractant

Strength:
200 mg

Form: Injection

Reference Brands: Survanta (US)

View Details
Poractant Alfa

Strength:
120 mg

Form: Injection

Reference Brands:

View Details
Poractant Alfa

Strength:
240 mg

Form: Injection

Reference Brands:

View Details
Dalteparin

Strength:
10000 IU

Form: Injection

Reference Brands: Fragmin (US/EU)

View Details
Brensocatib

Strength:
10mg, 25mg

Form: Tablets

Reference Brands: Brinsupri (USA/EU)

View Details
Mannitol

Strength:
40mg

Form: Capsule / Infusion

Reference Brands: Bronchitol (USA/EU)

View Details
Benralizumab

Strength:
30 mg/mL

Form: Injection

Reference Brands: Fasenra (USA/EU)

View Details
Umeclidinium Bromide

Strength:
62.5 mcg

Form: dry-powder inhaler

Reference Brands: Incruse Ellipta (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.